Literature DB >> 15937870

Muscle-fiber apoptosis in neuromuscular diseases.

Dominique S Tews1.   

Abstract

Muscle-fiber loss is a characteristic of many progressive neuromuscular disorders. Over the past decade, identification of a growing number of apoptosis-associated factors and events in pathological skeletal muscle provided increasing evidence that apoptotic cell-death mechanisms account significantly for muscle-fiber atrophy and loss in a wide spectrum of neuromuscular disorders. It became obvious that there is not one specific pathway for muscle fibers to undergo apoptotic degradation. In contrast, certain neuromuscular diseases seem to involve characteristic expression patterns of apoptosis-related factors and pathways. Furthermore, there are some characteristics of muscle-fiber apoptosis that rely on the muscle fiber itself as an extremely specified cell type. Multinucleated muscle fibers with successive muscle-fiber segments controlled by individual nuclei display some specifics different from apoptosis of mononucleated cells. This review focuses on the expression patterns of apoptosis-associated factors in different primary and secondary neuromuscular disorders and gives a synopsis of current knowledge. Muscle Nerve, 2005.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937870     DOI: 10.1002/mus.20348

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  19 in total

1.  In vivo time-lapse microscopy reveals no loss of murine myonuclei during weeks of muscle atrophy.

Authors:  Jo C Bruusgaard; Kristian Gundersen
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 2.  Excitation-transcription coupling in skeletal muscle: the molecular pathways of exercise.

Authors:  Kristian Gundersen
Journal:  Biol Rev Camb Philos Soc       Date:  2010-10-06

3.  Mechanism of neuromuscular dysfunction in Krabbe disease.

Authors:  Ludovico Cantuti-Castelvetri; Erick Maravilla; Michael Marshall; Tammy Tamayo; Ludovic D'auria; John Monge; James Jeffries; Tuba Sural-Fehr; Aurora Lopez-Rosas; Guannan Li; Kelly Garcia; Richard van Breemen; Charles Vite; Jesus Garcia; Ernesto R Bongarzone
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

4.  Cell death-resistance of differentiated myotubes is associated with enhanced anti-apoptotic mechanisms compared to myoblasts.

Authors:  Rijin Xiao; Amy L Ferry; Esther E Dupont-Versteegden
Journal:  Apoptosis       Date:  2011-03       Impact factor: 4.677

Review 5.  Cell death, clearance and immunity in the skeletal muscle.

Authors:  C Sciorati; E Rigamonti; A A Manfredi; P Rovere-Querini
Journal:  Cell Death Differ       Date:  2016-02-12       Impact factor: 15.828

6.  Caloric restriction delays aging-induced cellular phenotypes in rhesus monkey skeletal muscle.

Authors:  Susan H McKiernan; Ricki J Colman; Marisol Lopez; T Mark Beasley; Judd M Aiken; Rozalyn M Anderson; Richard Weindruch
Journal:  Exp Gerontol       Date:  2010-09-29       Impact factor: 4.032

7.  β-Hydroxy-β-methylbutyrate reduces myonuclear apoptosis during recovery from hind limb suspension-induced muscle fiber atrophy in aged rats.

Authors:  Yanlei Hao; Janna R Jackson; Yan Wang; Neile Edens; Suzette L Pereira; Stephen E Alway
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-22       Impact factor: 3.619

Review 8.  Nuclear domains during muscle atrophy: nuclei lost or paradigm lost?

Authors:  Kristian Gundersen; Jo C Bruusgaard
Journal:  J Physiol       Date:  2008-04-25       Impact factor: 5.182

Review 9.  Wasting mechanisms in muscular dystrophy.

Authors:  Jonghyun Shin; Marjan M Tajrishi; Yuji Ogura; Ashok Kumar
Journal:  Int J Biochem Cell Biol       Date:  2013-05-11       Impact factor: 5.085

10.  Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo.

Authors:  Julie Lagirand-Cantaloube; Karen Cornille; Alfredo Csibi; Sabrina Batonnet-Pichon; Marie Pierre Leibovitch; Serge A Leibovitch
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.